Complications Following Collagenase Treatment for Dupuytren Contracture

Jennifer Wozniczka, Clifford Canepa, Adam Mirarchi, Joel S. Solomon

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Background: Collagenase Clostridium histolyticum (CCH) injection and manipulation is a relatively new method for treating Dupuytren contracture that is growing in popularity. Although side effects such as swelling and ecchymosis are common, they are typically mild and self-limited. Major complications are rare but have included flexor tendon rupture and complex regional pain syndrome. Methods: This study describes a case report of 2 patients seen at our institution. Results: Here, we report 2 patients seen at our institution each with different, yet serious complications after CCH injection and manipulation. One patient had extensive skin loss and chose amputation over reconstruction. The other patient had loss of perfusion and required finger amputation. Conclusions: Although it is unclear how directly the administration of CCH is connected to the observed complications, physicians should recognize the potential for serious rare complications in any treatment of Dupuytren contracture.

Original languageEnglish (US)
Pages (from-to)NP148-NP151
Issue number5
StatePublished - Sep 1 2017


  • Dupuytren
  • Xiaflex
  • amputation
  • collagenase
  • epinephrine

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine


Dive into the research topics of 'Complications Following Collagenase Treatment for Dupuytren Contracture'. Together they form a unique fingerprint.

Cite this